Terminal Platelet Production is Regulated by Von Willebrand Factor

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Poirault Chassac, Sonia ^a,b   Nguyen, Kim Anh ^a,b   Pietrzyk, Audrey ^a,b   Casari, Caterina ^c,d   Veyradier, Agnes ^c,d,e   Denis, Cecile V ^c,d   Baruch, Dominique ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Dept Environ Med Natl Inst Publ HIth   (Norway)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; THROMBIN; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL; CONTROLLED STUDY; DRUG EFFICACY; GENOTYPE; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SHEAR RATE; SHEAR STRESS; THROMBOCYTE ADHESION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; VON WILLEBRAND DISEASE;

ANIMALS; BLOOD PLATELETS; CYTOSKELETON; HUMANS; MEGAKARYOCYTES; MICE; MICROTUBULES; PERFUSION; PLATELET ADHESIVENESS; STRESS, MECHANICAL; THROMBIN; THROMBOCYTOPENIA; THROMBOPOIESIS; VON WILLEBRAND DISEASE, TYPE 3; VON WILLEBRAND FACTOR;

DISCOIDAE; MURINAE; MUS;

EID: 84878478555     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063810     Document Type: Article

References (35)

1. Sporn LA, Marder VJ, Wagner DD, (1986) Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 46: 185-190.
2. Denis C, Baruch D, Kielty CM, Ajzenberg N, Christophe O, et al. (1993) Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen. Arterioscler Thromb 13: 398-406.
3. Bergmeier W, Chauhan A, Wagner D, (2008) Glycoprotein Ibalpha and von Willebrand factor in primary platelet adhesion and thrombus formation: lessons from mutant mice. Thromb Haemost 99: 264-270.
4. Mendolicchio GL, Ruggeri ZM, (2005) New perspectives on von Willebrand factor functions in hemostasis and thrombosis. Seminars in Hematology 42: 5-14.
5. Huizinga EG, Tsuji S, Romijn RA, Schiphorst ME, de Groot PG, et al. (2002) Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science 297: 1176-1179.
6. Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, et al. (1996) Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 88: 2939-2950.
7. Lenting P, Pegon J, Groot E, de Groot P, (2010) Regulation of von Willebrand factor-platelet interactions. Thromb Haemost 104: 449-455.
8. Kaushansky K, (2009) Determinants of platelet number and regulation of thrombopoiesis. Hematology 2009: 147-152.
9. Junt T, Schulze H, Chen Z, Massberg S, Goerge T, et al. (2007) Dynamic Visualization of Thrombopoiesis Within Bone Marrow. Science 317: 1767-1770.
10. Zucker-Franklin D, Philipp CS, (2000) Platelet Production in the Pulmonary Capillary Bed: New Ultrastructural Evidence for an Old Concept. Am J Pathol 157: 69-74.
11. Fuentes R, Wang Y, Hirsch J, Wang C, Rauova L, et al. (2010) Infusion of mature megakaryocytes into mice yields functional platelets. J Clin Invest 120: 3917-3922.
12. Scheinin TM, Koivuniemi AP, (1963) Megakaryocytes in the Pulmonary Circulation. Blood 22: 82-87.
13. Dunois-Larde C, Capron C, Fichelson S, Bauer T, Cramer-Borde E, et al. (2009) Exposure of human megakaryocytes to high shear rates accelerates platelet production. Blood 114: 1875-1883.
14. Schwertz H, Weyrich AS, (2010) Platelet precursors display bipolar behavior. The Journal of Cell Biology 191: 699-700.
15. Thon JN, Montalvo A, Patel-Hett S, Devine MT, Richardson JL, et al. (2010) Cytoskeletal mechanics of proplatelet maturation and platelet release. J Cell Biol 191: 861-874.
16. Schwertz H, Koster S, Kahr WHA, Michetti N, Kraemer BF, et al. (2010) Anucleate platelets generate progeny. Blood 115: 3801-3809.
17. Denis C, Methia N, Frenette PS, Rayburn H, Ullman-Cullere M, et al. (1998) A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A 95: 9524-9529.
18. Marx I, Christophe OD, Lenting PJ, Rupin A, Vallez M-O, et al. (2008) Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa. Blood 112: 603-609.
19. Ajzenberg N, Ribba AS, Rastegar-Lari G, Meyer D, Baruch D, (2000) Effect of recombinant von Willebrand factor reproducing type 2B or type 2M mutations on shear-induced platelet aggregation. Blood 95: 3796-3803.
20. Conant CG, Schwartz MA, Nevill T, Ionescu-Zanetti C (2009) Platelet adhesion and aggregation under flow using microfluidic flow cells. J Vis Exp 32: 1644 [pii].
21. Pergolizzi RG, Jin G, Chan D, Pierre L, Bussel J, et al. (2006) Correction of a murine model of von Willebrand disease by gene transfer. Blood 108: 862-869.
22. Patel SR, Richardson JL, Schulze H, Kahle E, Galjart N, et al. (2005) Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytes. Blood 106: 4076-4085.
23. Andre P, Denis CV, Ware J, Saffaripour S, Hynes RO, et al. (2000) Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood 96: 3322-3328.
24. Turner NA, Nolasco L, Ruggeri ZM, Moake JL, (2009) Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage. Blood 114: 5102-5111.
25. Giblin JP, Hewlett LJ, Hannah MJ, (2008) Basal secretion of von Willebrand factor from human endothelial cells. Blood 112: 957-964.
26. Nurden AT, (2005) Qualitative disorders of platelets and megakaryocytes. J Thromb Haemost 3: 1773-1782.
27. Strassel C, Eckly A, Leon C, Petitjean C, Freund M, et al. (2009) Intrinsic impaired proplatelet formation and microtubule coil assembly of megakaryocytes in a mouse model of Bernard-Soulier syndrome. Haematologica. 800-810.
28. Thon JN, Italiano JE (2012) Does size matter in platelet production? Blood.
29. Kirito K, Osawa M, Morita H, Shimizu R, Yamamoto M, et al. (2002) A functional role of Stat3 in in vivo megakaryopoiesis. Blood 99: 3220-3227.
30. Levin J, Cocault L, Demerens C, Challier C, Pauchard M, et al. (2001) Thrombocytopenic c-mpl-/- mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response. Blood 98: 1019-1027.
31. Patel-Hett S, Richardson JL, Schulze H, Drabek K, Isaac NA, et al. (2008) Visualization of microtubule growth in living platelets reveals a dynamic marginal band with multiple microtubules. Blood 111: 4605-4616.
32. Anderson NM, Berberovic Z, Berndl E, Bailey ML, Flenniken AM, et al. (2012) Cytopenia induction by 5-fluorouracil identifies thrombopoietic mutants in sensitized ENU mutagenesis screens. Experimental Hematology 40: 48-60.
33. Federici AB, Mannucci PM, Castaman G, Baronciani L, Bucciarelli P, et al. (2009) Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. Blood 113: 526-534.
34. Nurden P, Debili N, Vainchenker W, Bobe R, Bredoux R, et al. (2006) Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia. Blood 108: 2587-2595.
35. Rayes J, Hollestelle MJ, Legendre P, Marx I, de Groot PG, et al. (2010) Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B. Blood 115: 4870-4877.